Ritholtz Wealth Management Passage Bio, Inc. Transaction History
Ritholtz Wealth Management
- $4.45 Billion
- Q2 2025
A detailed history of Ritholtz Wealth Management transactions in Passage Bio, Inc. stock. As of the latest transaction made, Ritholtz Wealth Management holds 25,392 shares of PASG stock, worth $222,180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,392Holding current value
$222,180% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PASG
# of Institutions
41Shares Held
35.2MCall Options Held
40.5KPut Options Held
0-
Lynx1 Capital Management LP San Juan, PR9.26MShares$81 Million1.1% of portfolio
-
Vestal Point Capital, LP New York, NY6.1MShares$53.4 Million0.13% of portfolio
-
Orbimed Advisors LLC San Diego, CA6.06MShares$53 Million0.09% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$21.9 Million2.97% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$21.5 Million0.01% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $477M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...